Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography

Caio V Regatieri, Lauren Branchini, Jill Carmody, James G Fujimoto, Jay S Duker, Caio V Regatieri, Lauren Branchini, Jill Carmody, James G Fujimoto, Jay S Duker

Abstract

Purpose: This study was designed to examine choroidal thickness in patients with diabetes using spectral-domain optical coherence tomography.

Methods: Forty-nine patients (49 eyes) with diabetes and 24 age-matched normal subjects underwent high-definition raster scanning using spectral-domain optical coherence tomography with frame enhancement software. Patients with diabetes were classified into 3 groups: 11 patients with mild or moderate nonproliferative diabetic retinopathy and no macular edema, 18 patients with nonproliferative diabetic retinopathy and diabetic macular edema, and 20 patients with treated proliferative diabetic retinopathy and no diabetic macular edema (treated proliferative diabetic retinopathy). Choroidal thickness was measured from the posterior edge of the retinal pigment epithelium to the choroid/sclera junction at 500-μm intervals up to 2,500 μm temporal and nasal to the fovea.

Results: Reliable measurements of choroidal thickness were obtainable in 75.3% of eyes examined. Mean choroidal thickness showed a pattern of thinnest choroid nasally, thickening in the subfoveal region, and thinning again temporally in normal subjects and patients with diabetes. Mean subfoveal choroidal thickness was thinner in patients with diabetic macular edema (63.3 μm, 27.2%, P < 0.05) or treated proliferative diabetic retinopathy (69.6 μm, 30.0%, P < 0.01), compared with normal subjects. There was no difference between nonproliferative diabetic retinopathy and normal subjects.

Conclusion: Choroidal thickness is altered in diabetes and may be related to the severity of retinopathy. Presence of diabetic macular edema is associated with a significant decrease in the choroidal thickness.

Figures

Fig. 1
Fig. 1
Graph of mean CT in normal subjects and diabetic patients. Mean CT at each of the 11 locations measured at 500-μm (0.5 mm) intervals temporal (T) and nasal (N). P value represents the result of statistical analyses (analysis of variance).
Fig. 2
Fig. 2
Representative scans with CT measurements on Cirrus HD-OCT high-definition 1-line raster scans. Perpendicular lines were drawn from posterior edge of RPE to choroid/sclera junction using Cirrus HD-OCT software. Choroidal thickness was measured in the fovea and at 500-μm intervals nasal and temporal to the fovea with the measurements expressed as micrometers (red lines). Note that the choroid is thickest at center, thinner temporally, and thinnest nasally. A. Representative scan from a normal subject; (B) representative scan from a patient with mild non-proliferative diabetic retinopathy; (C) representative scan from a patient with moderate nonproliferative diabetic retinopathy and diabetic macular edema; (D) representative scan from a patient with treated proliferative diabetic retinopathy, note that there is a disruption in the photoreceptor inner/outer segment junction probably because of the retinal ischemia.
Fig. 3
Fig. 3
Graph of mean subfoveal CT in normal subjects and diabetic patients. P values represent the results of posttest comparison with Tukey multiple test.

References

    1. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105:998–1003.
    1. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217–1228.
    1. Hidayat AA, Fine BS. Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology. 1985;92:512–522.
    1. Weinberger D, Kramer M, Priel E, et al. Indocyanine green angiographic findings in nonproliferative diabetic retinopathy. Am J Ophthalmol. 1998;126:238–247.
    1. Shiragami C, Shiraga F, Matsuo T, et al. Risk factors for diabetic choroidopathy in patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2002;240:436–442.
    1. Cao J, McLeod S, Merges CA, Lutty GA. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol. 1998;116:589–597.
    1. Fukushima I, McLeod DS, Lutty GA. Intrachoroidal microvascular abnormality: a previously unrecognized form of choroidal neovascularization. Am J Ophthalmol. 1997;124:473–487.
    1. McLeod DS, Lutty GA. High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci. 1994;35:3799–3811.
    1. Bartsch DU, Weinreb RN, Zinser G, Freeman WR. Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol. 1995;120:642–651.
    1. Shiraki K, Moriwaki M, Kohno T, et al. Age-related scattered hypofluorescent spots on late-phase indocyanine green angiograms. Int Ophthalmol. 1999;23:105–109.
    1. Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004;88:1060–1063.
    1. Schocket LS, Brucker AJ, Niknam RM, et al. Foveolar choroidal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol. 2004;25:89–94.
    1. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811–815.
    1. Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009;148:445–450.
    1. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29:1469–1473.
    1. Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol. 2009;147:801–810.
    1. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010;150:325–329. e321.
    1. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998;105:360–370.
    1. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991;98:741–756.
    1. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.
    1. Ikuno Y, Kawaguchi K, Nouchi T, Yasuno Y. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci. 2010;51:2173–2176.
    1. Fryczkowski AW, Sato SE, Hodes BL. Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann Ophthalmol. 1988;20:299–305.
    1. Chen TC, Cense B, Miller JW, et al. Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol. 2006;141:1165–1168.
    1. Bourke K, Patel MR, Prisant LM, Marcus DM. Hypertensive choroidopathy. J Clin Hypertens (Greenwich) 2004;6:471–472.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi